These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 24012878)

  • 1. HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway.
    Kariya R; Taura M; Suzu S; Kai H; Katano H; Okada S
    Cancer Lett; 2014 Jan; 342(1):52-9. PubMed ID: 24012878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient inhibition of NF-kappaB by DHMEQ induces cell death of primary effusion lymphoma without HHV-8 reactivation.
    Dabaghmanesh N; Matsubara A; Miyake A; Nakano K; Ishida T; Katano H; Horie R; Umezawa K; Watanabe T
    Cancer Sci; 2009 Apr; 100(4):737-46. PubMed ID: 19469019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor.
    Lan K; Murakami M; Bajaj B; Kaul R; He Z; Gan R; Feldman M; Robertson ES
    Cancer Biol Ther; 2009 Nov; 8(22):2136-43. PubMed ID: 19783901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida.
    Ishikawa C; Mori N
    Oncol Rep; 2017 Nov; 38(5):3197-3204. PubMed ID: 29048633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma.
    Dai L; Trillo-Tinoco J; Cao Y; Bonstaff K; Doyle L; Del Valle L; Whitby D; Parsons C; Reiss K; Zabaleta J; Qin Z
    Blood; 2015 Dec; 126(26):2821-31. PubMed ID: 26531163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing new ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated lymphoma.
    Chen J; Goyal N; Dai L; Lin Z; Del Valle L; Zabaleta J; Liu J; Post SR; Foroozesh M; Qin Z
    Blood; 2020 Nov; 136(19):2175-2187. PubMed ID: 32518949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.
    Wong JP; Stuhlmiller TJ; Giffin LC; Lin C; Bigi R; Zhao J; Zhang W; Bravo Cruz AG; Park SI; Earp HS; Dittmer DP; Frye SV; Wang X; Johnson GL; Damania B
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16541-16550. PubMed ID: 31346082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.
    Nayar U; Sadek J; Reichel J; Hernandez-Hopkins D; Akar G; Barelli PJ; Sahai MA; Zhou H; Totonchy J; Jayabalan D; Niesvizky R; Guasparri I; Hassane D; Liu Y; Sei S; Shoemaker RH; Warren JD; Elemento O; Kaye KM; Cesarman E
    J Clin Invest; 2017 Jun; 127(6):2066-2080. PubMed ID: 28504647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.
    Sin SH; Roy D; Wang L; Staudt MR; Fakhari FD; Patel DD; Henry D; Harrington WJ; Damania BA; Dittmer DP
    Blood; 2007 Mar; 109(5):2165-73. PubMed ID: 17082322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the Bortezomib-induced cytotoxic and resistance mechanisms in a primary effusion lymphoma mouse model.
    Romeo MA; Focaccetti C; Arena A; Benedetti R; Di Crosta M; Palumbo C; Gilardini Montani MS; Santarelli R; Gonnella R; D'Orazi G; Bei R; Cirone M
    Hematol Oncol; 2024 Mar; 42(2):e3262. PubMed ID: 38450785
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
    Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S
    Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for Bladder Cancer: Efficacy and Synergistic Effects.
    Pereira M; Vale N
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Targeting the Cytochrome P450 Enzymes Using Lopinavir/Ritonavir in Colorectal Cancer: A Study in Monolayers, Spheroids and In Vivo Models.
    Alaei M; Nazari SE; Pourali G; Asadnia A; Moetamani-Ahmadi M; Fiuji H; Tanzadehpanah H; Asgharzadeh F; Babaei F; Khojasteh-Leylakoohi F; Saeed Gataa I; Ali Kiani M; Ferns GA; Lam AK; Hassanian SM; Khazaei M; Giovannetti E; Avan A
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review.
    Ali M; Wani SUD; Masoodi MH; Khan NA; Shivakumar HG; Osmani RMA; Khan KA
    Clin Complement Med Pharmacol; 2022 Dec; 2(4):100041. PubMed ID: 36377228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of
    Makgoo L; Mosebi S; Mbita Z
    Front Mol Biosci; 2022; 9():875208. PubMed ID: 35620479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and the role of cytokines in this disease.
    Hasanvand A
    Inflammopharmacology; 2022 Jun; 30(3):789-798. PubMed ID: 35505267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronaviruses construct an interconnection way with ERAD and autophagy.
    Movaqar A; Yaghoubi A; Rezaee SR; Jamehdar SA; Soleimanpour S
    Future Microbiol; 2021 Sep; 16(14):1135-1151. PubMed ID: 34468179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease.
    Davies DA; Adlimoghaddam A; Albensi BC
    Mol Neurobiol; 2021 Aug; 58(8):4178-4187. PubMed ID: 34075562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer.
    Marima R; Hull R; Dlamini Z; Penny C
    Front Oncol; 2020; 10():1693. PubMed ID: 32984047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs.
    Barillari G
    Front Oncol; 2020; 10():806. PubMed ID: 32528888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.